Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endogenous aldehydes: A driver of clonal hematopoiesis from within?

Cell stem cell·2026
Same author

Age-associated hematopoietic variants in the rhesus macaque.

Blood advances·2026
Same author

Stem cells and ageing in the blood: an interview with Margaret (Peggy) Goodell.

Disease models & mechanisms·2025
Same author

Author Correction: Clonal dynamics and somatic evolution of haematopoiesis in mouse.

Nature·2025
Same author

Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.

Nature genetics·2025
Same author

Author Correction: The long-term effects of chemotherapy on normal blood cells.

Nature genetics·2025

Related Experiment Video

Updated: Sep 21, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?

Linda Zhang1,2, Joanne I Hsu1,2, Margaret A Goodell2,3

  • 1Translational Biology and Molecular Medicine Graduate Program, Baylor College of Medicine, Houston, Texas.

Molecular Cancer Research : MCR
|June 3, 2022
PubMed
Summary

Protein phosphatase PPM1D regulates DNA damage response and is implicated in cancer. Mutations in PPM1D are frequent in clonal hematopoiesis and may drive leukemic transformation, impacting treatment strategies.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

286
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K

Related Experiment Videos

Last Updated: Sep 21, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

286
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The DNA damage response (DDR) is crucial for maintaining genome stability, and its failure is a hallmark of cancer.
  • Protein phosphatase Mg2+/Mn2+-dependent 1D (PPM1D) is a key negative regulator of the DDR, frequently altered in solid tumors.
  • PPM1D alterations correlate with aggressive cancer phenotypes and poor patient prognosis in solid malignancies.

Purpose of the Study:

  • To investigate the role of PPM1D in hematologic malignancies, particularly in the context of clonal hematopoiesis (CH).
  • To elucidate the mechanisms by which PPM1D mutations or overexpression contribute to cancer development.
  • To explore the differential roles of PPM1D in solid versus hematologic oncogenesis and identify potential therapeutic targets.

Main Methods:

  • Review of recent findings on PPM1D function in DNA damage response.
  • Analysis of large-scale genomic studies identifying PPM1D mutations in CH.
  • Examination of mechanisms including suppression of DNA repair, cell-cycle arrest, and apoptosis.

Main Results:

  • PPM1D is frequently mutated in individuals with CH, an age-associated phenomenon.
  • PPM1D mutations are enriched in therapy-related myeloid neoplasms, suggesting a role in leukemic transformation.
  • PPM1D alterations can impair DNA repair, cell-cycle arrest, and apoptosis, promoting malignancy.

Conclusions:

  • PPM1D plays a significant role in both solid and hematologic cancers.
  • Understanding PPM1D's function in CH and leukemogenesis is critical for developing new therapies.
  • Targeting PPM1D may offer novel therapeutic avenues for various malignancies.